| __timestamp | ADMA Biologics, Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3742367 | 129764000 |
| Thursday, January 1, 2015 | 4311461 | 152008000 |
| Friday, January 1, 2016 | 6360761 | 209620000 |
| Sunday, January 1, 2017 | 29164321 | 241786000 |
| Monday, January 1, 2018 | 42194635 | 315264000 |
| Tuesday, January 1, 2019 | 39504238 | 359466000 |
| Wednesday, January 1, 2020 | 61291426 | 524272000 |
| Friday, January 1, 2021 | 79769341 | 470515000 |
| Saturday, January 1, 2022 | 118814535 | 483669000 |
| Sunday, January 1, 2023 | 169273000 | 577065000 |
Cracking the code
In the ever-evolving landscape of biotechnology, understanding cost dynamics is crucial. Over the past decade, BioMarin Pharmaceutical Inc. and ADMA Biologics, Inc. have showcased distinct trajectories in their cost of revenue. From 2014 to 2023, BioMarin's cost of revenue surged by approximately 345%, peaking in 2023. This reflects their aggressive expansion and investment in innovative therapies. In contrast, ADMA Biologics experienced a staggering 4,420% increase, highlighting their rapid growth phase. Notably, ADMA's cost of revenue in 2023 was about 29% of BioMarin's, indicating a smaller scale but a significant upward trend. These insights underscore the competitive nature of the biotech sector, where strategic financial management can dictate market positioning. As both companies continue to innovate, monitoring these trends will be essential for stakeholders aiming to capitalize on future opportunities.
Cost of Revenue Trends: Merck & Co., Inc. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Comparison: Pfizer Inc. vs BioMarin Pharmaceutical Inc.
Cost of Revenue: Key Insights for Vertex Pharmaceuticals Incorporated and ADMA Biologics, Inc.
United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Bio-Techne Corporation and ADMA Biologics, Inc.'s Expenses
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs Sarepta Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Catalent, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs Cytokinetics, Incorporated
Catalent, Inc. vs ADMA Biologics, Inc.: Efficiency in Cost of Revenue Explored
Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: ADMA Biologics, Inc. vs Geron Corporation
Cost of Revenue Comparison: ADMA Biologics, Inc. vs Mesoblast Limited